4 free views remaining today

obsolete commensal Clostridium infectious disease

Description

Obsolete Commensal Clostridium Infectious Disease

Clostridium infections, also known as Clostridioides difficile (C. difficile), were once considered a relatively rare and minor gastrointestinal issue. However, with the advancement of medical research and increased awareness, it has become clear that these infections can have severe consequences.

Historical Context Initially described by Finney in 1893, Clostridium infections were initially thought to be a self-limiting condition. However, as cases emerged in hospitals in the 1950s, researchers began to understand the severity of this disease [10].

Types of Infections The most frequent Clostridial infection is minor, self-limited gastroenteritis, typically caused by C. perfringens type A [11]. Serious clostridial diseases are relatively rare but can be fatal.

Symptoms and Diagnosis The symptoms of Clostridium infections include fever, loss of appetite, nausea, and abdominal pain [1]. These symptoms can progress to severe conditions such as pseudomembranous colitis.

Prevalence and Impact Clostridioides difficile remains the most important cause of healthcare-associated diarrhea and has become the most commonly identified cause of healthcare-associated diarrhea worldwide [7][8].

Treatment and Prevention Clinical practice guidelines for Clostridium difficile infection in adults and children have been established to provide a framework for diagnosis, treatment, and prevention [14]. However, more research is needed to understand the full scope of this disease.

In summary, while Clostridium infections were once considered minor, they can have severe consequences. It is essential to be aware of the symptoms, prevalence, and impact of these infections to provide effective treatment and prevention strategies.

References: [1] - Symptoms include fever, loss of appetite, nausea and abdominal pain. [10] - Initially described by Finney in 1893 [11] - The most frequent Clostridial infection is minor, self-limited gastroenteritis, typically caused by C. perfringens type A. [7][8] - Clostridioides difficile remains the most important cause of healthcare-associated diarrhea and has become the most commonly identified cause of healthcare-associated diarrhea worldwide [14] - Clinical practice guidelines for Clostridium difficile infection in adults and children have been established

Additional Characteristics

  • Loss of appetite
  • Nausea
  • Fever
  • Pseudomembranous colitis
  • Abdominal pain
  • Gastroenteritis
  • Clostridioides difficile (C. difficile) infections

Signs and Symptoms

Common Signs and Symptoms of Obsolete Commensal Clostridium Infections

Clostridial infections, caused by the bacteria Clostridium, can manifest in various ways. While some forms are relatively rare, others are more common and can be serious. Here are some signs and symptoms associated with obsolete commensal Clostridium infections:

  • Gastroenteritis: Minor, self-limited gastroenteritis is a frequent clostridial infection, typically caused by C. perfringens type A [11].
  • Abdominal Disorders: Abdominal disorders such as cholecystitis, peritonitis, ruptured appendix, and bowel perforation can involve C. perfringens, C. ramosum, and many others [11].
  • Muscle Necrosis and Soft-Tissue Infection: Muscle necrosis and soft-tissue infection, which is relatively rare but can be fatal, can also occur due to Clostridium infections [11].

Important Notes

  • These symptoms are associated with obsolete commensal Clostridium infections, which may not be as common or relevant in modern medical practice.
  • The most frequent and well-known clostridial infection is C. difficile (C. diff), which causes diarrhea and colitis, but it's not included in this list as it's a more contemporary concern.

References

[11] The most frequent clostridial infection is minor, self-limited gastroenteritis, typically due to C. perfringens type A. [10] Clostridium paraputrificum occurs in the commensal intestinal flora and related bacteremia typically occurs secondary to an injury to the intestinal mucosa and in the presence of predisposing conditions. [11] Serious clostridial diseases are relatively rare but can be fatal.

Diagnostic Tests

Diagnostic Tests for Clostridium difficile Infection

Clostridium difficile (C. diff) is a type of bacteria that can cause a range of symptoms, from mild diarrhea to life-threatening colitis. Diagnosing C. diff infection requires a combination of clinical evaluation and laboratory testing.

Traditional Diagnostic Methods

Historically, the diagnosis of C. diff infection relied on traditional methods such as:

  • Toxin EIA (Enzyme Immunoassay): This test detects the presence of toxins produced by C. diff in stool samples [4]. However, it has been shown to have limitations in terms of specificity and sensitivity [3].
  • Glutamate Dehydrogenase (GDH) Test: This test detects the presence of GDH, a product of C. diff metabolism, in stool samples [7]. While it is relatively rapid and easy to perform, its sensitivity and specificity are not ideal.
  • Toxin B PCR (Polymerase Chain Reaction): This molecular test detects the presence of toxin B gene in stool samples [8]. It is highly sensitive and specific but can be time-consuming and requires specialized equipment.

Newer Diagnostic Methods

More recent advances in diagnostic testing include:

  • Nucleic Acid Amplification Tests (NAATs), such as PCR: These tests are highly sensitive and specific for detecting C. diff DNA in stool samples [9].
  • Stool Testing for Glutamate Dehydrogenase: This test detects the presence of GDH in stool samples and is often used in combination with other tests to confirm diagnosis.

Current Recommendations

The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) recommend a two-step testing algorithm for diagnosing C. diff infection, which includes an initial screening test followed by a confirmatory test [8].

In conclusion, while traditional diagnostic methods such as Toxin EIA and GDH tests are still used, newer methods like NAATs and stool testing for glutamate dehydrogenase offer improved sensitivity and specificity.

References:

[1] FDA-approved PCR assays are same-day tests that detect the presence of C. diff DNA in stool samples. [2] The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) recommend a two-step testing algorithm for diagnosing C. diff infection. [3] Toxin EIA has limitations in terms of specificity and sensitivity. [4] This test detects the presence of toxins produced by C. diff in stool samples. [5] Glutamate Dehydrogenase (GDH) Test detects the presence of GDH, a product of C. diff metabolism, in stool samples. [6] Toxin B PCR is highly sensitive and specific but can be time-consuming and requires specialized equipment. [7] Stool Testing for Glutamate Dehydrogenase detects the presence of GDH in stool samples. [8] The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) recommend a two-step testing algorithm for diagnosing C. diff infection. [9] Nucleic Acid Amplification Tests (NAATs), such as PCR, are highly sensitive and specific for detecting C. diff DNA in stool samples.

Treatment

Based on the provided context, it appears that you are looking for information on the drug treatment of an outdated or obsolete commensal Clostridium infection.

Treatment Options

According to the search results, the medications listed below are related to or used in the treatment of this condition:

  • Metronidazole
  • Vancomycin
  • Fidaxomicin

These antibiotics are commonly prescribed for treating Clostridioides difficile (C. diff) infections, which is a type of bacterial infection caused by an anaerobic, spore-forming, gram-positive bacillus.

Treatment Guidelines

The Infectious Diseases Society of America (ISDA) guidelines recommend the following treatment options:

  • For mild-to-moderate C. diff infections, oral metronidazole or vancomycin are recommended as first-line therapy.
  • For severe cases, oral vancomycin is preferred over metronidazole.
  • Fidaxomicin is also an option for treating C. diff infections.

Recurrence Prevention

It's worth noting that recurrent C. diff infections after a primary infection can be a major problem, with the risk being as high as 50 to 60 percent after three or more infections. In this case, avoiding a repeat of the initial treatment regimen may be recommended.

References:

  • [1] McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (ISDA) and ...
  • [3] Pharmacologic Treatment for the First Episode of Clostridium difficile Infection.
  • [4] Commonly prescribed medications include metronidazole, vancomycin, and fidaxomicin.
  • [5] Treatment of Mild-to-Moderate Clostridium difficile–associated Disease.

đź’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Based on the provided context, it appears that you are looking for information on the differential diagnosis of an outdated commensal Clostridium infectious disease.

The search results suggest that the disease in question is likely Clostridioides difficile (C. difficile), a bacterium that can cause a range of symptoms from mild diarrhea to life-threatening complications.

Here are some potential differential diagnoses for C. difficile infection, as mentioned in the context:

  • Other bacterial infections: The context mentions that a selected differential diagnosis is provided in Table 2, which may include other bacterial infections such as Salmonella, Shigella, and Campylobacter.
  • Viral gastroenteritis: The context also suggests that viral gastroenteritis (e.g., norovirus, rotavirus) could be considered in the differential diagnosis of C. difficile infection.
  • Inflammatory bowel disease (IBD): The context mentions that patients with underlying IBD (ulcerative colitis or Crohn's disease) may experience exacerbations of their condition secondary to C. difficile infection.

It is essential to note that these differential diagnoses are not exhaustive and may vary depending on the specific clinical presentation and patient population.

References:

  • [4] A selected differential diagnosis is provided in Table 2.
  • [14] The clinical presentation of CDI in patients with underlying IBD is often atypical, and patients may experience exacerbations of their condition secondary to C. difficile infection.
  • [15] Infection with toxin-producing Clostridium difficile strains is a common cause of diarrhea, which can be confused with other bacterial or viral infections.

Please let me know if you would like me to elaborate on any of these points or provide further information!

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10402
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:3584
core#notation
DOID:3584
oboInOwl#hasExactSynonym
clostridial infection
rdf-schema#label
obsolete commensal Clostridium infectious disease
owl#deprecated
true
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#gram-positive_bacterial_infectious_disease
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.